Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication

Journal Article · Sun Jul 01 00:00:00 EDT 1984 · J. Nucl. Med.; (United States)

OSTI ID:6679342

Allweiss, P; Braunstein, G D; Katz, A; Waxman, A

During a 4-yr period, ten of 87 patients (11/5%) who received therapeutic doses of radioactive iodine (I-131) for thyroid carcinoma developed acute and/or chronic sialadenitis involving the parotid (five patients) or submandibular (four patients) glands or both (one patient). Nine of the 10 patients had received prior I-131 therapy; the precipitating I-131 dose varied between 10 and 164 mCi. Onset of symptoms occurred between 1 day and 6 mo following therapy and the duration varied from 3 wk to 2 1/2 yr. This complication occurs more often than has been appreciated.

• Research Organization: Univ. of California, Los Angeles
• OSTI ID: 6679342
• Journal Information: J. Nucl. Med.; (United States), Vol. 25:7
• Country of Publication: United States
• Language: English

Related Subjects

63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
62 RADIOLOGY AND NUCLEAR MEDICINE
RADIOTHERAPY
SIDE EFFECTS
SALIVARY GLANDS
BIOLOGICAL RADIATION EFFECTS
CARCINOMAS
IODINE 131
PATIENTS
RADIATION DOSES
THYROID
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ENDOCRINE GLANDS
GLANDS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
THERAPY
560151* - Radiation Effects on Animals- Man
550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-)